Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 12Gastrointestinal 10Thoracic 4Lymphoid 3Sarcoma 2Other hematologic neoplasm 2Gynecologic 2Tumor-Agnostic 1Plasma cell 1Head & Neck 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enoxaparin × Thoracic × Clear all
NCT01058759 2018-08-22

Taxotere-Enoxaparin-(ENOXA)-Study

Hannover Medical School

Phase 3 Terminated
14 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00717938 2017-08-25

RASTEN

Lund University Hospital

Phase 3 Completed
390 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00771563 2013-06-28

SYRINGES

University Hospital, Antwerp

Phase 3 Completed
104 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00916669 2013-05-08

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Massachusetts General Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡